High Affinity Nerve Growth Factor Receptor Market, Global Outlook and Forecast 2022-2028
Report Code: KNJ1281577 No. of Pages: 103 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of High Affinity Nerve Growth Factor Receptor in Global, including the following market information:
Global High Affinity Nerve Growth Factor Receptor Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global High Affinity Nerve Growth Factor Receptor market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
ASP-7962 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of High Affinity Nerve Growth Factor Receptor include Array BioPharma Inc, Astellas Pharma Inc, AstraZeneca Plc, Daiichi Sankyo Co Ltd, Dompe Farmaceutici SpA, Genzyme Corp, Handok Inc, Ignyta Inc and Loxo Oncology Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the High Affinity Nerve Growth Factor Receptor companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global High Affinity Nerve Growth Factor Receptor Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global High Affinity Nerve Growth Factor Receptor Market Segment Percentages, by Type, 2021 (%)
ASP-7962
AZD-7451
BNN-27
Cenegermin
CRB-0089
Others
Global High Affinity Nerve Growth Factor Receptor Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global High Affinity Nerve Growth Factor Receptor Market Segment Percentages, by Application, 2021 (%)
Bile Duct Cancer
Papillary Thyroid Cancer
Low Back Pain
Lung Cancer
Others
Global High Affinity Nerve Growth Factor Receptor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global High Affinity Nerve Growth Factor Receptor Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies High Affinity Nerve Growth Factor Receptor revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies High Affinity Nerve Growth Factor Receptor revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Array BioPharma Inc
Astellas Pharma Inc
AstraZeneca Plc
Daiichi Sankyo Co Ltd
Dompe Farmaceutici SpA
Genzyme Corp
Handok Inc
Ignyta Inc
Loxo Oncology Inc
Merck & Co Inc
Nerviano Medical Sciences Srl
Plexxikon Inc
Proximagen Ltd
Rottapharm Biotech Srl
Sienna Biopharmaceuticals Inc
Tiziana Life Sciences Plc
1 Introduction to Research & Analysis Reports
1.1 High Affinity Nerve Growth Factor Receptor Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global High Affinity Nerve Growth Factor Receptor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global High Affinity Nerve Growth Factor Receptor Overall Market Size
2.1 Global High Affinity Nerve Growth Factor Receptor Market Size: 2021 VS 2028
2.2 Global High Affinity Nerve Growth Factor Receptor Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top High Affinity Nerve Growth Factor Receptor Players in Global Market
3.2 Top Global High Affinity Nerve Growth Factor Receptor Companies Ranked by Revenue
3.3 Global High Affinity Nerve Growth Factor Receptor Revenue by Companies
3.4 Top 3 and Top 5 High Affinity Nerve Growth Factor Receptor Companies in Global Market, by Revenue in 2021
3.5 Global Companies High Affinity Nerve Growth Factor Receptor Product Type
3.6 Tier 1, Tier 2 and Tier 3 High Affinity Nerve Growth Factor Receptor Players in Global Market
3.6.1 List of Global Tier 1 High Affinity Nerve Growth Factor Receptor Companies
3.6.2 List of Global Tier 2 and Tier 3 High Affinity Nerve Growth Factor Receptor Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global High Affinity Nerve Growth Factor Receptor Market Size Markets, 2021 & 2028
4.1.2 ASP-7962
4.1.3 AZD-7451
4.1.4 BNN-27
4.1.5 Cenegermin
4.1.6 CRB-0089
4.1.7 Others
4.2 By Type - Global High Affinity Nerve Growth Factor Receptor Revenue & Forecasts
4.2.1 By Type - Global High Affinity Nerve Growth Factor Receptor Revenue, 2017-2022
4.2.2 By Type - Global High Affinity Nerve Growth Factor Receptor Revenue, 2023-2028
4.2.3 By Type - Global High Affinity Nerve Growth Factor Receptor Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global High Affinity Nerve Growth Factor Receptor Market Size, 2021 & 2028
5.1.2 Bile Duct Cancer
5.1.3 Papillary Thyroid Cancer
5.1.4 Low Back Pain
5.1.5 Lung Cancer
5.1.6 Others
5.2 By Application - Global High Affinity Nerve Growth Factor Receptor Revenue & Forecasts
5.2.1 By Application - Global High Affinity Nerve Growth Factor Receptor Revenue, 2017-2022
5.2.2 By Application - Global High Affinity Nerve Growth Factor Receptor Revenue, 2023-2028
5.2.3 By Application - Global High Affinity Nerve Growth Factor Receptor Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global High Affinity Nerve Growth Factor Receptor Market Size, 2021 & 2028
6.2 By Region - Global High Affinity Nerve Growth Factor Receptor Revenue & Forecasts
6.2.1 By Region - Global High Affinity Nerve Growth Factor Receptor Revenue, 2017-2022
6.2.2 By Region - Global High Affinity Nerve Growth Factor Receptor Revenue, 2023-2028
6.2.3 By Region - Global High Affinity Nerve Growth Factor Receptor Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America High Affinity Nerve Growth Factor Receptor Revenue, 2017-2028
6.3.2 US High Affinity Nerve Growth Factor Receptor Market Size, 2017-2028
6.3.3 Canada High Affinity Nerve Growth Factor Receptor Market Size, 2017-2028
6.3.4 Mexico High Affinity Nerve Growth Factor Receptor Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe High Affinity Nerve Growth Factor Receptor Revenue, 2017-2028
6.4.2 Germany High Affinity Nerve Growth Factor Receptor Market Size, 2017-2028
6.4.3 France High Affinity Nerve Growth Factor Receptor Market Size, 2017-2028
6.4.4 U.K. High Affinity Nerve Growth Factor Receptor Market Size, 2017-2028
6.4.5 Italy High Affinity Nerve Growth Factor Receptor Market Size, 2017-2028
6.4.6 Russia High Affinity Nerve Growth Factor Receptor Market Size, 2017-2028
6.4.7 Nordic Countries High Affinity Nerve Growth Factor Receptor Market Size, 2017-2028
6.4.8 Benelux High Affinity Nerve Growth Factor Receptor Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia High Affinity Nerve Growth Factor Receptor Revenue, 2017-2028
6.5.2 China High Affinity Nerve Growth Factor Receptor Market Size, 2017-2028
6.5.3 Japan High Affinity Nerve Growth Factor Receptor Market Size, 2017-2028
6.5.4 South Korea High Affinity Nerve Growth Factor Receptor Market Size, 2017-2028
6.5.5 Southeast Asia High Affinity Nerve Growth Factor Receptor Market Size, 2017-2028
6.5.6 India High Affinity Nerve Growth Factor Receptor Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America High Affinity Nerve Growth Factor Receptor Revenue, 2017-2028
6.6.2 Brazil High Affinity Nerve Growth Factor Receptor Market Size, 2017-2028
6.6.3 Argentina High Affinity Nerve Growth Factor Receptor Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa High Affinity Nerve Growth Factor Receptor Revenue, 2017-2028
6.7.2 Turkey High Affinity Nerve Growth Factor Receptor Market Size, 2017-2028
6.7.3 Israel High Affinity Nerve Growth Factor Receptor Market Size, 2017-2028
6.7.4 Saudi Arabia High Affinity Nerve Growth Factor Receptor Market Size, 2017-2028
6.7.5 UAE High Affinity Nerve Growth Factor Receptor Market Size, 2017-2028
7 Players Profiles
7.1 Array BioPharma Inc
7.1.1 Array BioPharma Inc Corporate Summary
7.1.2 Array BioPharma Inc Business Overview
7.1.3 Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Major Product Offerings
7.1.4 Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Revenue in Global Market (2017-2022)
7.1.5 Array BioPharma Inc Key News
7.2 Astellas Pharma Inc
7.2.1 Astellas Pharma Inc Corporate Summary
7.2.2 Astellas Pharma Inc Business Overview
7.2.3 Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Major Product Offerings
7.2.4 Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Revenue in Global Market (2017-2022)
7.2.5 Astellas Pharma Inc Key News
7.3 AstraZeneca Plc
7.3.1 AstraZeneca Plc Corporate Summary
7.3.2 AstraZeneca Plc Business Overview
7.3.3 AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Major Product Offerings
7.3.4 AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Revenue in Global Market (2017-2022)
7.3.5 AstraZeneca Plc Key News
7.4 Daiichi Sankyo Co Ltd
7.4.1 Daiichi Sankyo Co Ltd Corporate Summary
7.4.2 Daiichi Sankyo Co Ltd Business Overview
7.4.3 Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Major Product Offerings
7.4.4 Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Revenue in Global Market (2017-2022)
7.4.5 Daiichi Sankyo Co Ltd Key News
7.5 Dompe Farmaceutici SpA
7.5.1 Dompe Farmaceutici SpA Corporate Summary
7.5.2 Dompe Farmaceutici SpA Business Overview
7.5.3 Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Major Product Offerings
7.5.4 Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Revenue in Global Market (2017-2022)
7.5.5 Dompe Farmaceutici SpA Key News
7.6 Genzyme Corp
7.6.1 Genzyme Corp Corporate Summary
7.6.2 Genzyme Corp Business Overview
7.6.3 Genzyme Corp High Affinity Nerve Growth Factor Receptor Major Product Offerings
7.6.4 Genzyme Corp High Affinity Nerve Growth Factor Receptor Revenue in Global Market (2017-2022)
7.6.5 Genzyme Corp Key News
7.7 Handok Inc
7.7.1 Handok Inc Corporate Summary
7.7.2 Handok Inc Business Overview
7.7.3 Handok Inc High Affinity Nerve Growth Factor Receptor Major Product Offerings
7.7.4 Handok Inc High Affinity Nerve Growth Factor Receptor Revenue in Global Market (2017-2022)
7.7.5 Handok Inc Key News
7.8 Ignyta Inc
7.8.1 Ignyta Inc Corporate Summary
7.8.2 Ignyta Inc Business Overview
7.8.3 Ignyta Inc High Affinity Nerve Growth Factor Receptor Major Product Offerings
7.8.4 Ignyta Inc High Affinity Nerve Growth Factor Receptor Revenue in Global Market (2017-2022)
7.8.5 Ignyta Inc Key News
7.9 Loxo Oncology Inc
7.9.1 Loxo Oncology Inc Corporate Summary
7.9.2 Loxo Oncology Inc Business Overview
7.9.3 Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Major Product Offerings
7.9.4 Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Revenue in Global Market (2017-2022)
7.9.5 Loxo Oncology Inc Key News
7.10 Merck & Co Inc
7.10.1 Merck & Co Inc Corporate Summary
7.10.2 Merck & Co Inc Business Overview
7.10.3 Merck & Co Inc High Affinity Nerve Growth Factor Receptor Major Product Offerings
7.10.4 Merck & Co Inc High Affinity Nerve Growth Factor Receptor Revenue in Global Market (2017-2022)
7.10.5 Merck & Co Inc Key News
7.11 Nerviano Medical Sciences Srl
7.11.1 Nerviano Medical Sciences Srl Corporate Summary
7.11.2 Nerviano Medical Sciences Srl Business Overview
7.11.3 Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Major Product Offerings
7.11.4 Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Revenue in Global Market (2017-2022)
7.11.5 Nerviano Medical Sciences Srl Key News
7.12 Plexxikon Inc
7.12.1 Plexxikon Inc Corporate Summary
7.12.2 Plexxikon Inc Business Overview
7.12.3 Plexxikon Inc High Affinity Nerve Growth Factor Receptor Major Product Offerings
7.12.4 Plexxikon Inc High Affinity Nerve Growth Factor Receptor Revenue in Global Market (2017-2022)
7.12.5 Plexxikon Inc Key News
7.13 Proximagen Ltd
7.13.1 Proximagen Ltd Corporate Summary
7.13.2 Proximagen Ltd Business Overview
7.13.3 Proximagen Ltd High Affinity Nerve Growth Factor Receptor Major Product Offerings
7.13.4 Proximagen Ltd High Affinity Nerve Growth Factor Receptor Revenue in Global Market (2017-2022)
7.13.5 Proximagen Ltd Key News
7.14 Rottapharm Biotech Srl
7.14.1 Rottapharm Biotech Srl Corporate Summary
7.14.2 Rottapharm Biotech Srl Business Overview
7.14.3 Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Major Product Offerings
7.14.4 Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Revenue in Global Market (2017-2022)
7.14.5 Rottapharm Biotech Srl Key News
7.15 Sienna Biopharmaceuticals Inc
7.15.1 Sienna Biopharmaceuticals Inc Corporate Summary
7.15.2 Sienna Biopharmaceuticals Inc Business Overview
7.15.3 Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Major Product Offerings
7.15.4 Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Revenue in Global Market (2017-2022)
7.15.5 Sienna Biopharmaceuticals Inc Key News
7.16 Tiziana Life Sciences Plc
7.16.1 Tiziana Life Sciences Plc Corporate Summary
7.16.2 Tiziana Life Sciences Plc Business Overview
7.16.3 Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Major Product Offerings
7.16.4 Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Revenue in Global Market (2017-2022)
7.16.5 Tiziana Life Sciences Plc Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com